Related Experiment Videos
Rat liver microsomal UDP-glucuronosyltransferase activity toward thyroxine: characterization, induction, and form
1Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City 66103.
Toxicology and Applied Pharmacology
|August 1, 1992
Summary
Thyroxine (T4) deactivation primarily occurs via glucuronidation by liver microsomal UDP-glucuronosyltransferase (UDP-GT). This study found that T4 glucuronidation is not specific to one UDP-GT form, as all tested enzyme inducers increased its activity.
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
Background:
- Thyroxine (T4) is a crucial thyroid hormone.
- UDP-glucuronosyltransferase (UDP-GT) enzymes are key in drug and xenobiotic metabolism.
- Glucuronidation is a major pathway for T4 deactivation in the liver.
Purpose of the Study:
- To characterize in vitro T4 UDP-GT activity in rat liver microsomes.
- To investigate if T4 glucuronidation is mediated by a specific UDP-GT form.
- To determine if microsomal enzyme inducers can enhance T4 glucuronidation.
Main Methods:
- Assessed T4 UDP-GT activity in hepatic microsomes from Wistar and Gunn rats.
- Administered four classes of UDP-GT inducers (phenobarbital, 3-methylcholanthrene, pregnenolone-16 alpha-carbonitrile, clofibrate) to Sprague-Dawley rats.
- Measured changes in T4 glucuronidation rates per milligram of microsomal protein and per kilogram of body weight.
Main Results:
- Gunn rats, deficient in certain UDP-GT forms, showed significantly lower T4 glucuronidation rates compared to Wistar rats.
- All four tested UDP-GT inducers (PB, 3MC, PCN, CLO) substantially increased T4 UDP-GT activity.
- Induction effects varied between per-milligram-protein and per-kilogram-body-weight measurements, but all showed significant increases.
Conclusions:
- T4 glucuronidation is mediated by multiple UDP-GT forms, not a single specific isoform.
- The deactivation of T4 can be significantly influenced by UDP-GT enzyme induction.
- These findings have implications for understanding T4 metabolism and drug interactions affecting thyroid hormone levels.